Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ibuprofen
- Therapeutic area
- Pain & musculoskeletal
- Drug class
- Analgesics / NSAIDs
- ATC
- M01AE
- Strength
- 200 mg
- Dosage form
- Tablet
- Pack
- 100's
- Registration no.
- 115526
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-10-09 03:22
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Kalos 200 mg tablet
Kalos 200 mg tablet contains Ibuprofen 200 mg. It is registered with DRAP by Citi pharma ltd (registration no. 115526). Its official price is PKR 394.32 for a pack of 100's, about PKR 3.94 per tablet. This price has applied since 27 July 2026. Kalos is also available as 400 mg tablet and 600 mg tablet. 46 other brands of Ibuprofen 200 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Kalos
Other brands of Ibuprofen 200 mg
Official price over time
No change in the official DRAP price is recorded for this pack (100's). Current price PKR 394.32, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Kalos 200 mg, 100's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/kalos-200-mg-115526-100s-citi-pharma-ltd/ (accessed 9 October 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 394.32 | 2026-07-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 115526Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
